Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma
PaperCitations, authors & open-access status
Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 1,406 citations, 2019 year and closed oa status.
1,406
Citations
2019
Year
closed
OA Status